Verastem: Maintaining "Buy" Rating Amid Upcoming Catalysts in 2026

jueves, 19 de marzo de 2026, 3:33 pm ET1 min de lectura
VSTM--

Verastem maintains a "Buy" rating as 1st half 2026 catalysts are in play. The company has a setback in targeting KRAS G12C NSCLC, but the author is optimistic about future prospects. The author downgraded Verastem to "Buy" based on this setback, but maintains a positive outlook for the company's future.

Verastem: Maintaining "Buy" Rating Amid Upcoming Catalysts in 2026

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios